13F-HR filed by Rosalind Advisors, Inc.
Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-07-12, with 40 holding rows worth $129,952,896.
- Accession
- 0001622627-24-000045
- Filer
- CIK 1622627
- Filed
- 2024-07-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 40 entries on the cover page, a total value of $129,952,896 stated on the cover page (in dollars after the unit check, H1), rows summing to $129,952,896 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 2,650,389 | $15,528,629 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 2,664,999 | $8,554,647 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 513,490 | $7,969,365 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 7,547,148 | $7,849,034 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 1,750,000 | $7,420,000 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 3,120,170 | $7,020,382 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 2,705,616 | $6,764,040 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,513,641 | $6,272,288 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 19,300,000 | $5,230,300 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 750,000 | $5,130,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 378,416 | $5,002,659 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 533,333 | $4,474,664 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 734,000 | $4,433,360 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,391,577 | $4,146,899 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 337,985 | $3,981,463 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 300,000 | $3,903,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 250,000 | $3,615,000 | dollars as filed | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 2,592,593 | $3,370,371 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T206 | COM | 450,000 | $3,321,000 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 2,696,003 | $2,268,147 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 416,800 | $1,792,240 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C957 | COM | 3,673 | $1,304,460 | dollars as filed | put |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 250,000 | $1,075,000 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T309 | COMMON | 255,555 | $1,073,331 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 22,403 | $1,044,338 | dollars as filed | put |
| FORTRESS BIOTECH INC | 34960Q307 | COM NEW | 607,797 | $1,039,333 | dollars as filed | |
| GERON CORP | 374163103 | COM | 200,000 | $848,000 | dollars as filed | |
| ANNOVIS BIO INC | 03615A958 | COM | 24,154 | $839,175 | dollars as filed | put |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 1,571,200 | $787,328 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,508,419 | $780,908 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 758,966 | $675,480 | dollars as filed | |
| JOURNEY MED CORP | 48115J109 | COM | 114,132 | $643,704 | dollars as filed | |
| BEYOND AIR INC | 08862L103 | COM | 903,614 | $485,511 | dollars as filed | |
| BIOFRONTERA INC | 09077D209 | COM NEW | 504,261 | $452,826 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ959 | PUT | 19,018 | $304,815 | dollars as filed | put |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 1,034,773 | $286,321 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 10,123 | $194,463 | dollars as filed | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 39,672 | $50,780 | dollars as filed | |
| TONIX PHARMACEUTICALS HL | 890260854 | COM | 28,154 | $19,635 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC | 02043Q957 | COM | 700 | $0 | dollars as filed | putValue filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001622627-24-000045 | this filing | 2024-07-12 | acceptance time not in the bulk data set |